top of page
Recruiting: Open

COVID-19 Booster Vaccine Trial

Clinical Trial

Description

  • Randomised double-blinded study

  • 3 study groups all receiving the same vaccine but stored under different conditions

  • The COVID-19 vaccine used is CV0801 - a monovalent modified-nucleoside mRNA COVID-19 vaccine encoding Ancestral D614G spike protein

Trial length

6 months

Participant age

Participant ages can range from 18 and above

Patient eligibility

  • Female participants must NOT be pregnant 

  • Female participants must NOT be breastfeeding

  • Healthy participants above the age of 18

  • No history of immunosuppressive or immunodeficient conditions

  • Prior receipt of an mRNA COVID-19 vaccine

    • This may be from a completed primary vaccination series or booster dose(s) of an approved or authorized mRNA COVID-19 vaccine

    • The last vaccination must be received at least 3 months prior to randomisation

2 onsite visits and 3 scheduled phone calls are required from patients

Follow-up inclusions

Objectives

To assess the immunogenicity of COVID-19 booster vaccines stored in different conditions.

Interested in participating?

Send us a message or give us a call here

Description

  • Randomised double-blinded study

  • 3 study groups all receiving the same vaccine but stored under different conditions

  • The COVID-19 vaccine used is CV0801 - a monovalent modified-nucleoside mRNA COVID-19 vaccine encoding Ancestral D614G spike protein

Trial length

6 months

Participant age

Participant ages can range from 18 and above.

Patient eligibility

  • Female participants must NOT be pregnant 

  • Female participants must NOT be breastfeeding

  • Healthy participants above the age of 18

  • No history of immunosuppressive or immunodeficient conditions

  • Prior receipt of an mRNA COVID-19 vaccine

  • This may be from a completed primary vaccination series or booster dose(s) of an approved or authorized mRNA COVID-19 vaccine

  • The last vaccination must be received at least 3 months prior to randomisation

2 onsite visits and 3 scheduled phone calls are required from patients.

Follow-up inclusions

Objectives

To assess the immunogenicity of COVID-19 booster vaccines stored in different conditions.

Interested in participating?

Send us a message or give us a call here

Recruiting: Open

COVID-19 Booster Vaccine Trial

Clinical Trial

Got questions?

Read our common queries about clinical trials, participation processes, safety measures, and more.

Get in touch with us

Our friendly team would love to hear from you! 

bottom of page